Farowski, Fedja, Els, Gregor, Tsakmaklis, Anastasia, Higgins, Paul G. ORCID: 0000-0001-8677-9454, Kahlert, Christian R. ORCID: 0000-0002-0784-3276, Stein-Thoeringer, Christoph K., Bobardt, Johanna S., Dettmer-Wilde, Katja, Oefner, Peter J., Vehreschild, Jorg Janne and Vehreschild, Maria J. G. T. (2019). Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales. Gut Microbes, 10 (2). S. 133 - 142. PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 1949-0984

Full text not available from this repository.

Abstract

Objectives: After allogeneic hematopoietic stem cell transplantation (allo-HCT), urinary levels of 3-indoxyl sulfate (3-IS) correlate with the relative abundance of bacteria from the class Clostridia (RAC), and antibiotic treatment is considered the major determinant of this outcome. A high RAC has been associated with favorable outcome after allo-HCT and protection from Clostridium difficile infection (CDI). We assessed correlations between alpha diversity, RAC and urinary 3-IS levels in a non-allo-HCT clinical cohort of antibiotic treated patients to further explore 3-IS as a biomarker of reduced diversity and predisposition to CDI. Methods: Fecal and urinary specimens were analyzed from 40 non-alto-HCT hospitalized patients before and 9 +/- 2 days after initiation of intravenous antibiotic treatment. Fecal microbiota were analyzed by 16s RNA sequencing and urinary 3-IS was analyzed by liquid chromatography-tandem mass spectrometry. Receiver operating characteristic (ROC) analysis was performed to assess the predictive value of 3-IS. Results: At a RAC cutoff of <30%, the binary logarithm of 3-IS (medium 3-IS: <= 2.5; high 3-IS: >2.5) was predictive with an accuracy of 82% (negative predictive value: 87%, positive predictive value 67%). Accuracy was improved by combing antibiotic history with 3-IS levels (accuracy 89%, npv 88%, ppv 92%). Conclusion: In conjunction with patient antibiotic history, 3-IS is a candidate marker to predict RAC.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Farowski, FedjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Els, GregorUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tsakmaklis, AnastasiaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Higgins, Paul G.UNSPECIFIEDorcid.org/0000-0001-8677-9454UNSPECIFIED
Kahlert, Christian R.UNSPECIFIEDorcid.org/0000-0002-0784-3276UNSPECIFIED
Stein-Thoeringer, Christoph K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bobardt, Johanna S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dettmer-Wilde, KatjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Oefner, Peter J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vehreschild, Jorg JanneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vehreschild, Maria J. G. T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-138828
DOI: 10.1080/19490976.2018.1502536
Journal or Publication Title: Gut Microbes
Volume: 10
Number: 2
Page Range: S. 133 - 142
Date: 2019
Publisher: TAYLOR & FRANCIS INC
Place of Publication: PHILADELPHIA
ISSN: 1949-0984
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
DIFFICILE-ASSOCIATED DISEASE; CELL TRANSPLANT RECIPIENTS; INFECTION; EPIDEMIOLOGY; ASSOCIATION; MORTALITY; IMPACTMultiple languages
Gastroenterology & Hepatology; MicrobiologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/13882

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item